These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
290 related items for PubMed ID: 12819072
21. Cross-sectional and longitudinal studies of naturally occurring antibodies to Pseudomonas aeruginosa in cystic fibrosis indicate absence of antibody-mediated protection and decline in opsonic quality after infection. Tosi MF, Zakem-Cloud H, Demko CA, Schreiber JR, Stern RC, Konstan MW, Berger M. J Infect Dis; 1995 Aug; 172(2):453-61. PubMed ID: 7622889 [Abstract] [Full Text] [Related]
22. Nonspecific immunoglobulin synthesis and elevated IgG levels in rabbits immunized with mucoid exopolysaccharide from cystic fibrosis isolates of Pseudomonas aeruginosa. Pier GB, Elcock ME. J Immunol; 1984 Aug; 133(2):734-9. PubMed ID: 6234359 [Abstract] [Full Text] [Related]
23. Role of alginate O acetylation in resistance of mucoid Pseudomonas aeruginosa to opsonic phagocytosis. Pier GB, Coleman F, Grout M, Franklin M, Ohman DE. Infect Immun; 2001 Mar; 69(3):1895-901. PubMed ID: 11179370 [Abstract] [Full Text] [Related]
24. Synthetic peptides representing epitopes of outer membrane protein F of Pseudomonas aeruginosa that elicit antibodies reactive with whole cells of heterologous immunotype strains of P. aeruginosa. Hughes EE, Gilleland LB, Gilleland HE. Infect Immun; 1992 Sep; 60(9):3497-503. PubMed ID: 1379985 [Abstract] [Full Text] [Related]
25. Construction and characterization of a live, attenuated aroA deletion mutant of Pseudomonas aeruginosa as a candidate intranasal vaccine. Priebe GP, Brinig MM, Hatano K, Grout M, Coleman FT, Pier GB, Goldberg JB. Infect Immun; 2002 Mar; 70(3):1507-17. PubMed ID: 11854239 [Abstract] [Full Text] [Related]
28. Immunization with outer membrane proteins (OprF and OprI) and flagellin B protects mice from pulmonary infection with mucoid and nonmucoid Pseudomonas aeruginosa. Hassan R, El-Naggar W, Abd El-Aziz AM, Shaaban M, Kenawy HI, Ali YM. J Microbiol Immunol Infect; 2018 Jun; 51(3):312-320. PubMed ID: 28291719 [Abstract] [Full Text] [Related]
30. Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses. Eichler I, Joris L, Hsu YP, Van Wye J, Bram R, Moss R. J Clin Invest; 1989 Dec; 84(6):1794-804. PubMed ID: 2512330 [Abstract] [Full Text] [Related]
31. Synthesis of sialyl Lewis(a) (sLe (a), CA19-9) and construction of an immunogenic sLe(a) vaccine. Ragupathi G, Damani P, Srivastava G, Srivastava O, Sucheck SJ, Ichikawa Y, Livingston PO. Cancer Immunol Immunother; 2009 Sep; 58(9):1397-405. PubMed ID: 19190907 [Abstract] [Full Text] [Related]
32. Protection against mucoid Pseudomonas aeruginosa in rodent models of endobronchial infections. Pier GB, Small GJ, Warren HB. Science; 1990 Aug 03; 249(4968):537-40. PubMed ID: 2116663 [Abstract] [Full Text] [Related]
33. Alginate--its role in neutrophil responses and signal transduction towards mucoid Pseudomonas aeruginosa bacteria. König B, Friedl P, Pedersen SS, König W. Int Arch Allergy Immunol; 1992 Aug 03; 99(1):98-106. PubMed ID: 1336422 [Abstract] [Full Text] [Related]
34. A preclinical study comparing approaches for augmenting the immunogenicity of a heptavalent KLH-conjugate vaccine against epithelial cancers. Ragupathi G, Koide F, Sathyan N, Kagan E, Spassova M, Bornmann W, Gregor P, Reis CA, Clausen H, Danishefsky SJ, Livingston PO. Cancer Immunol Immunother; 2003 Oct 03; 52(10):608-16. PubMed ID: 12811527 [Abstract] [Full Text] [Related]
35. Enhancement of the protective efficacy of an oprF DNA vaccine against Pseudomonas aeruginosa. Price BM, Barten Legutki J, Galloway DR, von Specht BU, Gilleland LB, Gilleland HE, Staczek J. FEMS Immunol Med Microbiol; 2002 Jun 03; 33(2):89-99. PubMed ID: 12052563 [Abstract] [Full Text] [Related]
36. Functional role of mucoid exopolysaccharide (alginate) in antibiotic-induced and polymorphonuclear leukocyte-mediated killing of Pseudomonas aeruginosa. Bayer AS, Speert DP, Park S, Tu J, Witt M, Nast CC, Norman DC. Infect Immun; 1991 Jan 03; 59(1):302-8. PubMed ID: 1898898 [Abstract] [Full Text] [Related]
37. Detection of antibodies to Pseudomonas aeruginosa alginate extracellular polysaccharide in animals and cystic fibrosis patients by enzyme-linked immunosorbent assay. Bryan LE, Kureishi A, Rabin HR. J Clin Microbiol; 1983 Aug 03; 18(2):276-82. PubMed ID: 6413528 [Abstract] [Full Text] [Related]
38. Immunochemical characterization of the mucoid exopolysaccharide of Pseudomonas aeruginosa. Pier GB, Matthews WJ, Eardley DD. J Infect Dis; 1983 Mar 03; 147(3):494-503. PubMed ID: 6220094 [Abstract] [Full Text] [Related]